Contemporary Fixed-Duration Treatment Options in the First-Line Setting of Chronic Lymphocytic Leukemia: Perspectives from a Publicly Funded Healthcare System.
Simple Summary: Contemporary drug combinations are or will soon be available for the first-line treatment of chronic lymphocytic leukemia that are provided to patients within a fixed duration. Hematologists from across Canada met to discuss the attributes of these options and share considerations fo...
| Publicado en: | Current Oncology Vol. 32; no. 10; pp. 543 - 557 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Oct2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |